Using Quantitative Systems Toxicology (QST) to Assess Drug Safety: The Experience of the DILIsimInitiative. ®
Drug-Induced Liver Injury (DILI)
1). Remains a major problem in drug development
2). The DILIsim Initiative is a public private partnership developing software capable to explaining and predicting DILI liability in new drug candidates.
Controlled Release Society Annual Meeting & Exposition, July 16-19, 2017, Boston, MA
By Paul B Watkins